Nyagrodhadi Ghanavati与催吐疗法治疗糖尿病的比较临床研究

A comparative clinical study of Nyagrodhadi Ghanavati and Virechana Karma in the management of Madhumeha.

作者信息

Kumari Jyoti, Mehta Charmi S, Shukla V D, Dave Alankruta R, Shingala Tushar M

机构信息

Department of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India.

出版信息

Ayu. 2010 Jul;31(3):300-4. doi: 10.4103/0974-8520.77152.

DOI:10.4103/0974-8520.77152

PMID:22131730

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3221062/

Abstract

Diabetes mellitus is a common chronic metabolic disorder prevalent all over the world. Virechana is the Shodhana procedure that is specific for the elimination of vitiated Pitta and Kapha doshas. Thus, in the present study, the Virechana process has been selected prior to the administration of Shamana drug. Nyagrodhadi churna is mentioned in Chakradatta, which is modified into Ghana form for easy administration and dose maintenance. The present study was conducted in two groups: Group A, Nyogrodhadi Ghana vati (Shamana therapy) and Group B, Virechana and Nyogrodhadi Ghana vati (combined therapy). A total of 42 patients were registered for the present study, in which 34 patients completed the and eight patients were dropouts. After evaluating the total effect of the therapies, it was observed that the Virechana and Nyagrodhadi Ghanavati (combined therapy) provided better relief in the patients of Madhumeha in comparison with Nyagrodhadi Ghanavati (Shamana therapy) alone.

摘要

糖尿病是一种在全球普遍存在的常见慢性代谢紊乱疾病。催吐法是一种专门用于清除失调的皮塔（Pitta）和卡法（Kapha）体液的净化疗法。因此，在本研究中，在给予舒缓药物之前选择了催吐法。《查克拉达塔》（Chakradatta）中提到了尼耶格罗达迪药粉（Nyagrodhadi churna），将其制成加纳剂型以便于服用和维持剂量。本研究分为两组进行：A组，尼耶格罗达迪加纳丸剂（舒缓疗法）；B组，催吐法与尼耶格罗达迪加纳丸剂（联合疗法）。本研究共登记了42例患者，其中34例患者完成了研究，8例患者退出。在评估了这些疗法的总体效果后，观察到与单独使用尼耶格罗达迪加纳丸剂（舒缓疗法）相比，催吐法与尼耶格罗达迪加纳丸剂（联合疗法）能为糖尿病患者提供更好的缓解效果。